글로벌 직접 소비자(DTC) 유전자 검사 시장 – 2030년까지의 산업 동향 및 예측

직접 소비자(DTC) 유전자 검사 시장 분석 및 규모

직접 소비자(DTC) 검사는 직접 접근 검사라고도 하며, 고객이 의료 서비스 제공자와 협력할 필요 없이 실험실에서 직접 검사를 주문할 수 있습니다. 예측 기간 동안 직접 소비자(DTC) 유전자 검사 시장 성장을 촉진할 것으로 예상되는 주요 요인은 대중의 경각심 증가입니다. 나아가, 선진국의 소득 수준이 증가함에 따라 직접 소비자(DTC) 유전자 검사 시장 성장이 더욱 촉진될 것으로 예상됩니다.

Data Bridge Market Research는 직접 소비자(DTC) 유전자 검사 시장이 2022년에 1,550.51백만 달러 규모였으며 2030년까지 3,880.35백만 달러에 도달할 것으로 추산하고 2023년에서 2030년까지의 예측 기간 동안 12.15%의 CAGR로 성장할 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research가 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함되어 있습니다.

직접 소비자(DTC) 유전자 검사 시장 범위 및 세분화

시장 정의

글로벌 직접 소비자(DTC) 유전자 검사 시장은 의료 전문가나 중개자의 개입 없이 유전자 검사 서비스와 제품이 소비자에게 직접 판매되는 시장을 말합니다. DTC 유전자 검사를 통해 개인은 자신의 유전자 정보에 접근하여 조상 추적, 건강 위험 평가, 개인화된 의학을 포함한 다양한 목적으로 분석할 수 있습니다. 이 시장에는 유전자 검사 키트, 온라인 검사 주문 및 결과 해석 플랫폼, 관련 서비스를 제공하는 회사가 포함됩니다.

직접 소비자(DTC) 유전자 검사 시장 역학

운전자

• 소비자 인식 증가

Growing public awareness of the benefits of genetic testing, including ancestry, disease risk assessment, and personalized healthcare insights, has increased the demand for DTC genetic testing. Consumers are becoming more proactive about their health and want convenient and accessible ways to obtain genetic information.

• Rising Technological Advancements

Advances in gene sequencing technology and bioinformatics have greatly reduced the cost and time required for genetic testing. Technological advancements have led to a significant reduction in the cost of genetic testing. The development of high-throughput sequencing technologies, such as next-generation sequencing (NGS), has enabled the analysis of multiple genes or even entire genomes at a fraction of the cost compared to traditional methods.

• Growing Personalized Healthcare and Wellness Trends

The rise in focus on personalized healthcare and wellness, the demand for DTC genetic testing is increasing. Consumers are increasingly interested in understanding their genetic makeup to make informed decisions about their lifestyle, disease prevention, and treatment options. DTC genetic testing provides individuals with valuable insight into their unique genetic profile, enabling a personalized health approach.

Opportunity

• Rapid Expansion of Test Offerings

DTC genetic testing companies have an opportunity to diversify their testing portfolio and expand beyond parenthood and basic health-related testing. Companies are offering a wider range of genetic tests, including pharmacogenomics, nutrigenomics and carrier screening. Companies can target a wider audience and provide more comprehensive genetic insights. This will act as an opportunity for market growth.

• Increasing Partnerships with Healthcare Providers

Continued collaboration between DTC genetic testing companies and healthcare providers creates an opportunity for a more integrated and holistic approach to genetic testing. Partnering with medical institutions, DTC companies can leverage their expertise and build trust to ensure responsible use and interpretation of genetic data.

Restraints

• Lack of Data Privacy and Ethical Concerns

The DTC genetic testing market faces challenges related to data protection and the responsible use of genetic information. Genetic testing involves the collection and analysis of personal genomic data, which raises ethical and privacy concerns. Consumers may have reservations about sharing their genetic information with companies due to potential risks of unauthorized access, data breaches, or misuse of information. These concerns can limit market growth as individuals prioritize the security and privacy of their genetic data.

Challenges

• Strict Regulatory Landscape

The DTC genetic testing market operates in a complex regulatory environment. Different countries have different regulations and guidelines regarding genetic testing, data protection and the involvement of health professionals. Adapting to changing regulatory requirements and maintaining compliance can be a significant challenge for companies operating in this market.

This direct-to-consumer (DTC) genetic testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the direct-to-consumer (DTC) genetic testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In March 2021, 23andMe announced its plans to go public through a merger with a special purpose acquisition company (SPAC) called VG Acquisition Corp. The merger aimed to accelerate the company's growth and expand its consumer health offerings
• In February 2021, MyHeritage, a leading genealogy and genetic testing company, introduced a new product called MyHeritage Health. It combined genetic testing with family history research to provide users with a comprehensive understanding of their health risks and genetic heritage.

Global Direct-to-Consumer (DTC) Genetic Testing Market Scope

The global Direct-to-Consumer (DTC) Genetic Testing Market is segmented into seven notable segments based on service, test type, technology, product type, business model, end user, and sales channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Service

• Diagnostic screening
• Prenatal
• New-born screening
• Pre-implantation diagnosis
• Relationship testing

Test Type

• Carrier testing
• Predictive testing
• Ancestry and relationship testing
• Nutrigenomics testing and others

Technology

• Targeted analysis
• Single nucleotide polymorphism (SNP) chips
• Whole genome sequencing (WGS)

Product Type

• Ancestry
• Health and wellness
• Entertainment

Business Model

• Genome data bank material model
• Individual health planning model
• Comprehensive genome tests model
• Medical precision tests model
• Restricted trait tests model

End User

• Laboratories
• Blood banks
• Nursing homes
• Hospitals
• Imaging centers
• Home care
• Cosmetics
• Others

Sales Channel

• Online sales
• OTC sales
• Doctor's office

Global Direct-to-Consumer (DTC) Genetic Testing Market Regional Analysis/Insights

The global direct-to-consumer (DTC) genetic testing market is analyzed, and market size insights and trends are provided based on service, test type, technology, product type, business model, end user and sales channel.

The countries covered in this global direct-to-consumer (DTC) genetic testing market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the direct-to-consumer (DTC) genetic testing market due to the shift in the outlook of consumers toward genetic testing. Furthermore, the rise in expenditure will further boost the growth of the direct-to-consumer (DTC) genetic testing market in the region during the forecast period.

 Asia-Pacific is projected to observe a significant amount of growth in the direct-to-consumer (DTC) genetic testing market due to the rise in health care awareness. Moreover, the increase in disposable income is further anticipated to propel the growth of the direct-to-consumer (DTC) genetic testing market in the region in the coming years.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The direct-to-consumer (DTC) genetic testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the direct-to-consumer (DTC) genetic testing market, impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the direct-to-consumer (DTC) genetic testing market. The data is available for the historic period 2015-2020.

Competitive Landscape and Direct-to-consumer (DTC) Genetic Testing Market Share Analysis

직접 소비자(DTC) 유전자 검사 시장 경쟁 구도는 경쟁업체의 세부 정보를 제공합니다. 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세 등이 포함됩니다. 위에 제공된 데이터 포인트는 직접 소비자(DTC) 유전자 검사 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 직접 소비자(DTC) 유전자 검사 시장에서 활동하는 주요 업체는 다음과 같습니다.

• 이지DNA(미국)
• 조상(미국)
• 23andMe, Inc. (미국)
• 컬러 헬스(Color Health, Inc.)(미국)
• 제네시스 헬스케어(미국)
• Full Genomes Corporation, Inc.(미국)
• 헬릭스 옵코 LLC (미국)
• Living DNA Ltd (영국)
• Mapmygenome(인도)
• 게놈웹(미국)
• Gene by Gene, Ltd. (미국)
• MyHeritage Ltd. (이스라엘)
• 10x Genomics(미국)
• Dante Labs, Inc. (미국)
• 24Genetics(스페인)
• Laboratory Corporation of America Holdings (미국)
• Myriad Genetics, Inc. (미국)
• Quest Diagnostics Incorporated(미국)
• 유니오젠 오이(칠면조)

SKU-47726